Emergent BioSolutions Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Emergent BioSolutions Inc. on April 8, 2011, covering an event that occurred on April 6, 2011. The filing discloses the entry into a material definitive agreement regarding strategic consulting services.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the new consulting agreement:
- Consulting Fee: $15,000 per month.
- Expenses: Reimbursement of reasonable out-of-pocket expenses.
- Contract Term: One year, effective April 1, 2011, expiring April 1, 2012.
Material Changes
The Company entered into a new consulting services agreement with The Hauer Group, replacing a prior agreement that expired on April 1, 2011. The new agreement continues to provide strategic consulting and domestic and international marketing advice.
Management Commentary and Related Party Transactions
The agreement involves a related party transaction. Jerome Hauer, a member of the Company's Board of Directors, is the chief executive officer and sole owner of The Hauer Group. The agreement may be extended by mutual agreement upon expiration.
Key Facts for Investor Verification
- Verify the total annual cost of the consulting agreement ($180,000 in fees plus expenses).
- Confirm the specific scope of "strategic consulting and marketing advice" provided by The Hauer Group.
- Review the Company's related party transaction policies and Board approval processes for this agreement.
- Check for any other pending or expired agreements with The Hauer Group not detailed in this filing.